Synthesis, molecular modelling, and evaluation of new mono- and bis-isoxazolines as antibacterial agents: <i>in vitro</i> and <i>in silico</i> analysis.

RSC Adv · 2026 · PMC13185690 · PMID 42164295

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a positive trendno p-value reported

While these results indicate a positive trend in the 4-series, these values remain considerably lower than those of Ciprofloxacin (32 ± 0.01 mm) and Co-trimoxazole (31 ± 0.01 mm).

also in 7,469 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Synthesis, molecular modelling, and evaluation of new mono- and bis-isoxazolines as antibacterial agents: &lt;i&gt;in vitro&lt;/i&gt; and &lt;i&gt;in silico&lt;/i&gt; analysis.

The sentences

Synthesis, molecular modelling, and evaluation of new mono- and bis-isoxazolines as antibacterial agents: <i>in vitro</i> and <i>in silico</i> analysis.